Year: 2021

ANDOVER, Mass., Nov. 19, 2021 (GLOBE NEWSWIRE) — Casa Systems, Inc. (Nasdaq: CASA), a leading provider of cloud-native and physical infrastructure technology solutions for wireless, cable and fixed broadband networks, will host its 2021 Virtual Investor Day today. The event can be found at https://investors.casa-systems.com and will begin at 9 a.m. Eastern Standard Time followed by a Q&A session with key executives. Key Event HighlightsCasa Systems is deploying a disruptive, end-to-end connected cloud solution to help customers generate new revenue from 5G, rural, and mobile private networks (MPN). Tens of billions of dollars will be spent to transform networks for 5G, rural and MPN. Long-Term Financial Outlook, Refinancing and Deleveraging Plans“Casa is in the process of a multi-year transformation from a hardware-heavy...

Series  RIKB 24 0415 RIKS 33 0321Settlement Date  11/24/2021 11/24/2021Total Amount Allocated (MM)  3,400 3,050All Bids Awarded At (Price / Yield)  97.514 / 3.600 125.070 / 0.690Total Number of Bids Received  14 27Total Amount of All Bids Received (MM)  4,100 5,030Total Number of Successful Bids  11 16Number of Bids Allocated in Full  11 16Lowest Price / Highest Yield Allocated  97.514 / 3.600 125.070 / 0.690Highest Price / Lowest Yield Allocated  97.647 / 3.540 125.450 / 0.659Lowest Price / Highest Yield Allocated in Full  97.514 / 3.600 125.070 / 0.690Weighted Average of Successful Bids (Price/Yield)  97.557 / 3.580 125.271 / 0.674Best Bid (Price / Yield)  97.647 / 3.540 125.450 / 0.659Worst Bid (Price / Yield)  97.425 / 3.640 124.699 / 0.720Weighted Average of All Bids Received (Price / Yield)  97.541 / 3.590 125.117 / 0.686Percentage...

MAINZ, GERMANY, November 19, 2021 — BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track Designation for BNT111, an investigational cancer immunotherapy for the potential treatment of advanced melanoma. BNT111 is the lead product candidate from BioNTech’s fully owned FixVac platform that utilizes a fixed combination of mRNA-encoded, tumor-associated antigens aiming to trigger a strong and precise immune response against cancer. The vaccine candidate is currently being investigated in a Phase 2 trial (EudraCT No.: 2020-002195-12; NCT04526899) in patients with anti-PD-1-refractory/relapsed unresectable Stage III or IV melanoma. “The Fast Track Designation underlines the potential of our FixVac platform to address current treatment challenges of pre-treated...

Kvika will host its Capital Markets Day on 26 November, beginning at 13:00 p.m. until 16:30 p.m. GMT. Kvika’s senior management will offer post-merger updates on the company’s operations and business model in addition to giving deeper insights into individual business units. The event will also highlight Kvika’s strategy and growth opportunities along with key financial goals and developments. A live stream of the event can be accessed by registering here. Presentations will be conducted in Icelandic, however, all presentation material is in English and will be made available shortly ahead of the event on Kvika’s website. For further information or enquiries, please contact fjarfestatengsl@kvika.is

Yara BirkelandYara International ASANorwegian Prime Minister, Jonas Gahr Støre celebrates the unveiling of Yara Birkeland in OsloMinister of Fisheries and Ocean Policy Bjørnar Skjæran, Prime Minister Jonas Gahr Støre, CEO Yara Svein Tore Holsether, CEO Kongsberg Gruppen Geir Håøy.Yara BirkelandYara International ASAOslo, 19 November 2021: The world’s first electric and self-propelled container ship – Yara Birkeland – has departed for its maiden voyage in the Oslo fjord. Today, the Norwegian Prime Minister was given a tour by CEO of Yara, Svein Tore Holsether. “We are proud to be able to showcase the world’s first fully electric and self-propelled container ship. It will cut 1,000 tonnes of CO2 and replace 40,000 trips by diesel-powered trucks a year, says Svein Tore Holsether,...

ST. JOHN’S, Newfoundland and Labrador, Nov. 19, 2021 (GLOBE NEWSWIRE) — David Hutchens, President and CEO, Fortis Inc. (“Fortis” or the “Corporation”) (TSX/NYSE: FTS) today appointed Gary Smith to the position of Executive Vice President, Operations and Innovation effective January 1, 2022. Smith is currently Executive Vice President, Eastern Canadian and Caribbean Operations. “Gary Smith has dedicated three decades to the Fortis organization, providing leadership in the areas of energy delivery, operations and customer service,” said David Hutchens. “As Incident Commander of our COVID-19 emergency response and leader of the Fortis Operating Group, Gary champions a safety culture and puts employees and customers at the forefront of every decision.” Creating a cleaner, more resilient...

NEW YORK, Nov. 19, 2021 (GLOBE NEWSWIRE) — Brooklyn ImmunoTherapeutics, Inc. (Nasdaq: BTX) (“Brooklyn”) today announced that on November 18, 2021 it filed with the Securities and Exchange Commission a registration statement on Form S-1 relating to the proposed public offering by certain selling stockholders of up to 6,281,454 shares of Brooklyn’s common stock received in connection with Brooklyn’s acquisition of Novellus, Inc. in July 2021. Brooklyn will not receive any proceeds from any shares sold by the selling stockholders. A registration statement relating to the proposed sale of these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. The...

HOUSTON, Nov. 19, 2021 (GLOBE NEWSWIRE) — W&T Offshore, Inc. (NYSE: WTI) (“W&T” or the “Company”) today announced that the Company was the apparent high bidder on two blocks in the Gulf of Mexico Lease Sale 257 held by the Bureau of Ocean Energy Management (“BOEM”) on November 17, 2021. W&T will also be participating in two upcoming investor conferences. Lease Sale 257 W&T was the apparent high bidder in the most recent Gulf of Mexico lease sale on two shallow water blocks, Eugene Island South Addition block 385 and Ship Shoal South Addition block 360. These two blocks cover a total of approximately 10,000 gross acres. If awarded, the Company will pay approximately $295,000 in total for the awarded leases combined, which reflect a 100% working interest in the acreage. The blocks have a lease term of five years...

PRC Clinical to Provide Start-up CRO Services for BRTX-100 Phase 2 Clinical Trial MELVILLE, N.Y., Nov. 19, 2021 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ:BRTX), a life sciences company focused on adult stem cell-based therapies, today announced that it has entered into a letter of intent with PRC Clinical, a CRO specializing in clinical trial management, with regard to PRC Clinical providing startup clinical project management activities for the Company’s BRTX-100 Phase 2 clinical trial to treat chronic lumbar disc disease. “We are pleased to announce that we have entered into a letter of intent for PRC Clinical to provide startup activities for our Phase 2 study. PRC has extensive experience and expertise in managing clinical studies in the stem cell and regenerative medicine...

HANGZHOU, China, Nov. 19, 2021 (GLOBE NEWSWIRE) — UTStarcom (“UT” or the “Company”) (NASDAQ: UTSI), a global telecommunications infrastructure provider, today announced that Ms. Wendong Zhang resigned from the Company’s Board of Directors (the “Board”) effective November 16, 2021 to pursue other business interests.  Ms. Zhang also served on various board committees, including the Audit Committee, the Compensation Committee, and the Nominating and Corporate Governance Committee. Following Ms. Zhang’s resignation, Mr. Hao Zheng was appointed as a member of the Board, the Audit Committee, the Compensation Committee, and the Nominating and Corporate Governance Committee of the Board, effective November 17, 2021.  Mr. Zheng is the designee of Beijing E-town International Investment Development Co., Ltd. (“BEIID”), pursuant to the stockholders...